Named on 2 rounds in the feed, most often at Series A and in Biotech.
Rounds from 2025-04-08 to 2025-10-09
ROUNDS
2
led 1, joined 1
LED ROUNDS · USD
$40.3M
across 1 round · 1 co-led, split evenly
CO-INVESTORS
13
named beside it
Named on 2 rounds in the feed, most often at Series A and in Biotech.
Rounds from 2025-04-08 to 2025-10-09
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Expedition Therapeutics - Expedition Therapeutics develops novel treatments for inflammatory and respiratory diseases, specifically targeting chronic obstructive pulmonary disease (COPD). | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $165M | 2025-10-09 | [ PART ] |
Merida Biosciences Merida Biosciences develops precision therapies for autoimmune-driven diseases targeting pathogenic drivers of antibody-driven diseases. | Series A Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $121M | 2025-04-08 | [ LEAD ] |